Studies on a bioactive peptide QUB-2044 from the skin secretion of the Chinese frog, Odorrana schmackeri

Read full text Summarise with VIRAT
Authors: Yilihamu Maierhaba
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Nature has been recognised as the most bountiful source for new therapeutics, among which amphibians have been the focus of research in the search for new compounds with biological activities as a result of the abundant bioactive contents of their skins. So far, a great number of pharmacological and antimicrobial peptides (AMPs) have been successfully isolated and identified from the skin and associated secretions of amphibians. Furthermore, some of these peptides have been recognised as significant novel drug leads. This thesis focused on the study of an AMP from the defensive skin secretions of Odorrana schmackeri. The precursor structure was identified by a strategy of molecular cloning and was subjected to an NCBI-BLAST search and CLUSTAL OMEGA sequence alignment, from which the amino acid sequence of the mature peptide was deduced as: GILKGILGMGKNLVCGLSGLC. The peptide was synthesised using Solid Phase Peptide Synthesis and subjected to a range of biological assays. In the antimicrobial assay, the synthetic peptide exerted a strong inhibitory activity against S.aureus and a relatively moderate one against E.coli and C.albicans with the MIC values being 16 μM, 32 μM and 32 μM, respectively, and showed mild cytotoxicity against red blood cells at these concentrations. However, the peptide did not show significant anti-cancer activity.

Fields of Study & Subjects

Antimicrobial Peptides and Activities Chemical Synthesis and Analysis Microbial Natural Products and Biosynthesis

Publication details

Journal / source
Research Portal (Queen's University Belfast)
Publication date
1 October 2026
Language
EN
Document type
Thesis